Whooping cough

Whooping cough is a respiratory infection caused by the bacterium Bordetella pertussis, characterized by bouts of coughing acute. Disease can lead to serious complications especially in infants and small children and is therefore a matter of public health concern road. Although whooping cough is a vaccine-preventable disease, it can still cause outbreaks especially in unvaccinated populations. The clinical course of the disease consists of three main stages, with severe coughing fits most prominent during the second stage.

The causative agent of whooping cough, Bordetella pertussis, is a Gram-negative bacterium. Bacterium adheres to respiratory tract epithelial cells and secretes toxins that cause the symptoms of the disease. Whooping cough is transmitted from person to person via respiratory secretions.

1. Airborne: Inhalation of droplets released by infected individuals through coughing or sneezing.
2. Close Contact: Prolonged and close contact with infected individuals.
3. Contagiousness: The disease exhibits high contagiousness, particularly during the early stage (catarrhal phase).

The clinical course of whooping cough is divided into three main stages: the catarrhal stage, the paroxysmal stage, and the convalescent stage. Each stage has distinct symptoms.

• Occurs during the first 1 to 2 weeks of illness.
• Symptoms resemble those of a common cold: runny nose, mild cough, sneezing and low-grade fever.
• The disease is highly contagious during this stage.

• Occurs during weeks 2 to 6 of illness.
• Severe coughing fits occur, consisting of rapid, successive coughs.
• Following a coughing fit, a high-pitched “whoop” sound may be heard during deep inhalation.
• Vomiting, cyanosis and fatigue may occur during coughing episodes.
• This stage can be life-threatening especially in infants.

• Begins after the sixth week of illness.
• The severity and frequency of coughing fits gradually decrease.
• The recovery process may last several weeks or months.

The diagnosis of whooping cough is confirmed by clinical findings and laboratory tests. Nose and throat swab samples can confirm the presence of Bordetella pertussis through culture or PCR testing.

Antibiotics are used in the treatment of whooping cough. Early initiation of antibiotic treatment reduces the severity and contagiousness of the disease. The antibiotics used include:

1. Macrolides: Erythromycin, azithromycin or clarithromycin.
2. Alternative Agents: Trimethoprim-sulfamethoxazole for patients with penicillin allergy.

Additionally, supportive therapies such as fluid replacement and oxygen care are administered especially in severe cases.

Whooping cough can lead to serious complications, especially in infants and young children. These complications include:

1. Pneumonia: The most common complication.
2. Seizures: May occur due to hypoxia resulting from severe coughing fits.
3. Brain Damage: Encephalopathy may develop in severe cases due to hypoxia.
4. Death: Can be fatal, particularly in unvaccinated infants.

Whooping cough is a vaccine-preventable disease. The whooping cough vaccine is typically administered as part of the diphtheria, tetanus and pertussis (DTaP) vaccine combination. Immunization programs play a critical role in controlling the disease.

1. Infants and Children: The DTaP vaccine is given at 2, 4, 6 and 18 months of age and again between 4 and 6 years.
2. Adolescents and Adults: The Tdap vaccine is recommended during adolescence and as a booster every 10 years in adults.
3. Pregnant Women: Tdap vaccination is recommended during each pregnancy to protect the newborn after birth.